PSYGDPsyence Group Inc.

About Psyence Group Inc. (PSYGD)

Psyence Group Inc. (PSYGD) is a Drug Manufacturers - General company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.

Psyence is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. Our vision is that our enduring work expands access to mental wellness and nurtures community. We will achieve this by developing and providing innovative, safe and effective psychedelic and nature-centred solutions for mental health and palliative care.

Products and services

Psyence is a life science biotechnology company pioneering the use of natural psychedelics in the treatment of psychological trauma and mental health disorders. The Company has a particular focus on these conditions in the context of palliative care.

PSYGD key facts

Ticker symbol

PSYGD

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - General

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

1994

Employees

20

Estimated market cap

$1.04M (as of May 13, 2025)

Shares outstanding

9,387,612

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

3/31

Latest filing

Interim Financial Report (Jun 30, 2023)

Psyence Group Inc. leadership

• Neil Maresky — CEO
• Warwick Coden-Lloyd — CFO
• Taryn Vos — General Counsel

Explore more: Drug Manufacturers - General stocks · Healthcare sector · Pink stocks · OTC stocks starting with P